Supernus Pharmaceuticals
SUPN
SUPN
249 hedge funds and large institutions have $1.72B invested in Supernus Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 91 increasing their positions, 89 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
3% less funds holding
Funds holding: 258 → 249 (-9)
14% less capital invested
Capital invested by funds: $2.01B → $1.72B (-$283M)
24% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 38
Holders
249
Holding in Top 10
3
Calls
$2.54M
Puts
$343K
Top Buyers
| 1 | +$24M | |
| 2 | +$18.5M | |
| 3 | +$16.1M | |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$15.7M |
| 5 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
+$7.33M |
Top Sellers
| 1 | -$13M | |
| 2 | -$10.5M | |
| 3 | -$6.27M | |
| 4 |
LCG
Lisanti Capital Growth
New York
|
-$5.79M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$4.85M |